Company Filing History:
Years Active: 2016-2025
Title: Lucio Robledo: Innovator in Optical Coherence Tomography
Introduction
Lucio Robledo is a prominent inventor based in Bern, Switzerland. He has made significant contributions to the field of ophthalmology through his innovative work in optical coherence tomography (OCT). With a total of 10 patents to his name, Robledo continues to push the boundaries of technology in eye care.
Latest Patents
Robledo's latest patents include an optical coherence tomography system designed for ophthalmology. This system captures data representing structures in the eye, particularly for creating cross-sectional images. By generating multiple A-scans using swept-source OCT at various locations in the eye, the system records reflection values for numerous points along a light trace. The combined values from these reflection values enhance data quality by fitting a model of a curved structure in the eye to the reflection values. This method allows for improved resolution and reduced noise in the data. Another notable patent involves an OCT system that includes an OCT light source and a detector for capturing interference signals. This system can sense two measurement regions that are separated from each other, showcasing the versatility and effectiveness of Robledo's inventions.
Career Highlights
Lucio Robledo has established himself as a key figure in the field of optical technologies. His work at Haag-Streit AG has allowed him to collaborate with other experts in the field, further enhancing the impact of his inventions. His dedication to improving ophthalmic imaging techniques has made a significant difference in patient care.
Collaborations
Robledo has worked alongside notable colleagues such as Peter Stalder and André Meznaric. Their combined expertise has contributed to the advancement of OCT technologies and their applications in ophthalmology.
Conclusion
Lucio Robledo's innovative contributions to optical coherence tomography have revolutionized the way eye care is approached. His patents reflect a commitment to enhancing the quality of ophthalmic imaging, ultimately benefiting patients worldwide.